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Background: SIRT1 is likely to play a role in the extension in healthspan induced by dietary restriction. Actions of
SIRT1 are pleiotropic, and effects on healthspan may include effects on DNA methylation. Polycomb group protein
target genes (PCGTs) are suppressed by epigenetic mechanisms in stem cells, partly through the actions of the
polycomb repressive complexes (PRCs), and have been shown previously to correspond with loci particularly
susceptible to age-related changes in DNA methylation. We hypothesised that SIRT1 would affect DNA methylation
particularly at PCGTs. To map the sites in the genome where SIRT1 affects DNA methylation, we altered SIRT1
expression in human intestinal (Caco-2) and vascular endothelial (HuVEC) cells by transient transfection with an
expression construct or with siRNA. DNA was enriched for the methylated fraction then sequenced (HuVEC) or
hybridised to a human promoter microarray (Caco-2).
Results: The profile of genes where SIRT1 manipulation affected DNA methylation was enriched for PCGTs in both cell
lines, thus supporting our hypothesis. SIRT1 knockdown affected the mRNA for none of seven PRC components nor for
DNMT1 or DNMT3b. We thus find no evidence that SIRT1 affects DNA methylation at PCGTs by affecting the expression
of these gene transcripts. EZH2, a component of PRC2 that can affect DNA methylation through association with DNA
methyltransferases (DNMTs), did not co-immunoprecipitate with SIRT1, and SIRT1 knockdown did not affect the
expression of EZH2 protein. Thus, it is unlikely that the effects of SIRT1 on DNA methylation at PCGTs are mediated
through direct intermolecular association with EZH2 or through effects in its expression.
Conclusions: SIRT1 affects DNA methylation across the genome, but particularly at PCGTs. Although the mechanism
through which SIRT1 has these effects is yet to be uncovered, this action is likely to contribute to extended healthspan,
for example under conditions of dietary restriction.
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The DNA methylation profile of the vertebrate genome
changes over time, reflected as a change in total
methyl-cytosine content [1, 2]. These changes have
been mapped to specific sites in species including mice
[3, 4] and humans [5–8], revealing a drift in DNA
methylation across most of the genome with components
that are both tissue specific and tissue independent [4, 9].* Correspondence: dianne.ford@ncl.ac.uk
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creativecommons.org/publicdomain/zero/1.0/A notable feature of the age-related drift in DNA methyla-
tion is that hypermethylation clusters at the gene targets
of polycomb group proteins (PCGTs), as observed in
human whole blood from postmenopausal women [7],
mouse intestine [4] and mouse haematopoietic stem cells
[3]. Several arguments and observations support the
premise that epigenetic changes, such as changes in DNA
methylation, contribute to the ageing process. For ex-
ample, the fundamental role of epigenetic reprogramming
in the process of gamete formation, which must reverse
the ageing clock to prevent progressively shortened life-
span in each successive generation, provides a compellingarticle distributed under the terms of the Creative Commons Attribution
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etic reprogramming to restore pluripotency in the success
of somatic cell nuclear transfer [10]. Also consistent with
the premise that epigenetic changes contribute to ageing is
that extended lifespan can be inherited trans-generationally
in Caenorhabditis elegans via genes that are components
of a major epigenetic modifier—the histone H3 lysine 4
trimethylation (H3K4me3) complex [11]. The polycomb
group proteins bind to PCGTs as polycomb repressive
complexes (PRCs). PCGTs are repressed by mechanisms
involving chromatin modification in stem cells and must
be expressed to achieve cell differentiation [12]. PCGTs
also tend to be hypermethylated in cancer [13–15].
We showed recently that manipulating the expression
of the histone deacetylase SIRT1 in human cells affected
promoter DNA methylation of a small panel of genes
that we tested, selected on the basis that they have been
reported to show an age-related change in DNA methy-
lation and to be expressed differentially in response to
dietary restriction (DR), an intervention shown robustly
in multiple species to increase lifespan and/or health-
span [16]. The view that SIRT1 contributes to increased
healthspan and/or lifespan, including under conditions
of DR, is controversial. The supporting literature is ex-
tensive and is covered by recent reviews (e.g. [17, 18]).
Notable recent developments include the observation
that male and female transgenic mice that overexpress
Sirt1 specifically in the brain had extended lifespan and
enhanced neural activity in the dorsomedial and lateral
hypothalamic nuclei [19]. It appears, however, that some
earlier work in model organisms proposed to demonstrate
that the gene homologues of SIRT1 confer extended life-
span requires re-evaluation. For example, extended life-
span in strains of C. elegans transgenic for Sir2 tracked
with loci other than the transgene [20]. Also, confounding
effects of genetic manipulation used to create Sir2 trans-
genic Drosophila, rather than the Sir2 transgene per se,
appear to be responsible for the long-lived phenotype
[20]. However, the debate has been re-opened by reports
including that lifespan was extended in Drosophila when
Sir2 expression was manipulated using an inducible sys-
tem that eliminated genetic background as a confounding
factor [21]. Also, a body of other recent data show consist-
ently effects on mammalian physiology commensurate
with sirtuins having actions that protect against features
of ageing (reviewed in [22]). Intermediates in pleiotropic
cellular pathways and several key transcription factors
with likely effects on healthspan are substrates for deace-
tylation by SIRT1. These substrates include PGC1α, which
controls mitochondrial biogenesis, p53 [23] and many
others [24]. Our discovery that SIRT1 affects DNA methy-
lation with a bias towards genes that also show altered ex-
pression in response to dietary restriction [16] uncovers a
novel and fundamental function of SIRT1 with likelyparticular relevance to its effects on healthspan. Recent
reviews provide a fuller exposition of evidence supporting
the view that SIRT1 has a role in healthspan (e.g. [25]).
Here we hypothesised that altering the level of SIRT1
expression would affect DNA methylation on a genome-
wide basis and target preferentially genes, including
PCGTs, where DNA methylation is affected by increasing
age. Supporting our hypothesis, we made the fundamen-
tally important observation that effects of SIRT1 on DNA
methylation do indeed cluster particularly at PCGTs.
Results
Manipulating SIRT1 expression affects DNA methylation
across the genome
We increased SIRT1 expression by transient transfection
with a plasmid construct or reduced expression using
siRNA (as in our previous work [16]) to measure the
effect on DNA methylation across the genome in two
different human cell line models—HuVECs (vascular
endothelial) and (as used in our previous work) Caco-2
(intestinal) cells. Efficacy of overexpression or knock-
down for HuVECs was confirmed by RT-qPCR and
Western blotting (Fig. 1) and has been shown previously
for Caco-2 cells [16]. DNA was enriched for the methyl-
ated component and compared to the input sample. For
HuVECs, a recombinant H6-GST-MBD protein was bound
to fragmented DNA, and then the methylated fraction was
captured on magnetic beads coated with GSH. Input and
enriched samples were then sequenced, and reads were
mapped to the human genome then filtered to those
within 2 kb of a transcription start site or within genes
(between the TSS and stop codon). The data are depos-
ited under GEO accession number GSE54072 [26]. Dif-
ferentially methylated genes were identified using the
package MEDIPS (Bioconductor) then classified as
hypomethylated or hypermethylated when SIRT1 ex-
pression was increased or reduced. For Caco-2 cells,
DNA was enriched for the methylated fraction by
MeDIP using an antibody recognising 5-methylcytidine
(5mC), and efficacy was confirmed by measuring en-
richment by qPCR of a lambda phage DNA added as a
spike to all samples in both a demethylated and in vitro-
methylated form and of two loci known to be hyper-
methylated (H19 and L1.2) relative to a hypomethylated
locus (UBE2B) [27]. Comparing input and immunopre-
cipitated samples, the lambda phage spike was enriched
1000–12,000-fold and the endogenous hypermethylated
versus hypomethylated loci were enriched 40–270-fold
(see Additional file 1), thus confirming efficacy. Input
and enriched samples were co-hybridised to the human
3x720K CpG Island Plus RefSeq Promoter Array (Nim-
bleGen). The data are deposited under GEO accession
number GSE53569 [28]. Genes were scored as methyl-
ated differently under conditions of SIRT1 knockdown
AC
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Fig. 1 Confirmation of SIRT1 overexpression and knockdown in HuVECs. a Measurement of SIRT1 mRNA by RT-qPCR. Data are for n = 4–8.
Measurement of SIRT1 by Western blotting following transient transfection with plasmid pCMV6-ENTRY-SIRT1 (Origene) or with vector control (b) or
with siRNA targeted to SIRT1 or with control siRNA (c). Approximately 10 μg of protein was loaded in each lane. Three biological replicates are presented
for each condition. Approximate molecular weights are indicated. “+SIRT1” indicates cells transfected with pCMV6-ENTRY-SIRT1; “control” indicates cells
tranfected with vector control; “siRNA” indicates cells transfected with one of two siRNAs (#1 or #2) targeted to SIRT1 or with a control siRNA. Data are
representative of multiple independent repeats of the procedure
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Fig. 2 Intersections between lists of genes that showed positive or
negative DNA methylation responses to SIRT1. Data are shown for
HuVECs and Caco-2 cells, as defined in the key. P values were
derived using chi-square analysis applying Yates’ correction
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or other list of enriched genes.
For ease of reference, we refer to genes that lost DNA
methylation with SIRT1 knockdown and/or gained DNA
methylation with SIRT1 overexpression as having a posi-
tive DNA methylation response to SIRT1. Conversely,
we classify genes that responded to SIRT1 in an opposite
direction as having a negative response to SIRT1. A total
of 1554 genes in HuVECs [29] and 1845 genes in Caco-2
cells [29] showed a positive DNA methylation response
to SIRT1[29], of which 139 (a larger number than ex-
pected by chance; P < 0.001) were common to both cell
lines (Fig. 2). Similarly, the two different cell lines shared
a subset of genes that showed a negative DNA methyla-
tion response to SIRT1 that was greater than expected
by chance (P = 0.005), comprising 49 genes from a total
of 1475 in HuVECs [29] and 873 in Caco-2 cells [29]
(Fig. 2).
PCGTs are over-represented among genes for which DNA
methylation is affected by SIRT1 manipulation
We determined if PCGTs were over-represented in our
list of genes that responded to SIRT1 using lists derived
by performing genome-wide location analysis of DNA
immunoprecipitated by antibodies against core compo-
nents of polycomb repressive complex 1 (PRC1) (Phc1
and Rnf2) and PRC2 (Suz12 and Eed) [30]. This analysis
is summarised in Table 1. Gene targets of each individ-
ual component of PRC1 or PRC2, or targets of at least
one component, were all enriched 1.3 to 1.8-fold in
genes we found to show a positive DNA methylationresponse to SIRT1 in both cell lines (with the exception
of targets of Rnf2 in HuVECs). Similarly, genes identified
as targets of ALL components of PRC1 and PRC2 were
enriched (1.6 to 2.2-fold) in the genes showing a positive
DNA methylation response to SIRT1. We found a simi-
lar relationship between genes that showed a negative
DNA methylation response to SIRT1 and PCGTs. Gene
targets of each individual component of PRC1 or PRC2
as well as gene targets of at least one component were
all enriched 1.3 to 1.7-fold in these gene lists derived
Table 1 Analysis of the size of intersections between polycomb group protein target genes (PCGTs) and genes with higher levels of
DNA methylation
HuVEC Caco-2
Positive response to SIRT1 Negative response to SIRT1 Positive response to SIRT1 Negative response to SIRT1
RF P RF P RF P RF P
Suz12 targets 1.5 <0.0001 1.5 =0.0008 1.6 <0.0001 1.5 =0.0088
Eed targets 1.4 =0.0102 1.1 =0.4573 1.8 <0.0001 1.5 =0.0347
Phc1 targets 1.4 =0.0069 1.3 <0.0001 1.6 <0.0001 1.7 =0.0004
Rnf2 targets 1.2 =0.0853 1.3 =0.0341 1.7 <0.0001 1.7 =0.0012
Targets of all polycomb
group proteins
1.6 <0.0001 1.1 =0.6135 2.2 <0.0001 1.4 =0.1355
Targets of at least one
polycomb group protein
1.3 =0.0090 1.3 =0.0046 1.5 <0.0001 1.6 <0.0001
Analysis of the size of intersections between polycomb group protein target genes (PCGTs) and genes with higher levels of DNA methylation under control
conditions and/or reduced levels of DNA methylation under conditions of SIRT1 knockdown (positive response to SIRT1) or genes with reduced levels of DNA
methylation under control conditions and/or higher levels of DNA methylation under conditions of SIRT1 knockdown (negative response to SIRT1). PCGT lists were
compiled from published data (Boyer et al. 2006). RF (representation factor) values show the ratio of observed to expected number of genes in the intersection.
P values were derived using chi-square analysis applying Yates’ correction. Italicized cells indicate where data did not reach statistical significance
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Genes identified as targets of ALL components of PRC1
and PRC2 [30], however, were not enriched in the lists
of genes that responded negatively to SIRT1.
Polycomb group protein mRNA levels are not affected by
SIRT1 manipulation
The chromatin modifications that repress PCGTs in
stem cells result partly from actions of the polycomb
group proteins themselves to effect epigenetic modifica-
tion [31], including DNA methylation [32]. Thus, we
proposed that SIRT1 may affect DNA methylation at
PCGTs by changing the level of expression of polycomb
group proteins. We investigated this hypothesis by deter-
mining the effect of SIRT1 knockdown in HuVECs and
Caco-2 cells on the relative level of mRNA for individual
polycomb group proteins (components of PRC1 and
PRC2). We also determined if SIRT1 knockdown af-
fected the mRNA for the histone demethylase KDM2B,
which has been shown to recruit PRC1 to CpG islands
[33]. None of the mRNAs measured was changed con-
sistently when SIRT1 expression was reduced using both
siRNAs (separately) (Fig. 3). Increases in SUZ12, EZH2,
BMI1 and PHC1 mRNAs in HuVECs and in RNF2
mRNA in Caco-2 cells were observed using only one of
the two siRNAs in each instance. Given that the second
siRNA was equally effective in reducing SIRT1 expres-
sion, then these responses cannot be attributed to SIRT1
knockdown. Off-target effects of the siRNA on genes
that influence the expression of these polycomb group
protein mRNAs is a possible explanation for these obser-
vations. We thus found no evidence to support the idea
that SIRT1 affects DNA methylation at PCGTs by effects
on the expression of PRC components.SIRT1 does not affect the quantity of EZH2 protein in the
cell nor associate with EZH2
It has been shown that the histone methyltransferase
EZH2 (a component of PRC2) associates with DNA
methyltransferases (DNMTs) and is necessary to recruit
DNMTs to EZH2-repressed genes [32]. Also, an inter-
molecular association between recombinant SIRT1 and
EZH2 was observed in HeLa cells. [34]. We thus rea-
soned that effects on EZH2 were a likely point of action
through which SIRT1 affects DNA methylation at PCGTs.
To explore further if SIRT1 affects the expression of
EZH2, we determined by Western blotting if SIRT1 knock-
down affected EZH2 protein expression in Caco-2 cells
and saw no effect (Fig. 4). We also investigated if EZH2
co-immunoprecipitated with SIRT1. We achieved success-
ful immunoprecipitation of both SIRT1 and EZH2 from
Caco-2 cells and HuVECs but detected no EZH2 in the
protein fraction enriched using anti-SIRT1 antibody and
no SIRT1 in the protein fraction enriched using anti-EZH2
antibody (Fig. 5). We thus found no evidence that SIRT1
and EZH2 form an intermolecular complex in these cell
lines.
Discussion
Our findings make an important contribution to key de-
velopments in understanding how age-related changes in
DNA methylation contribute to the process of ageing, a
field where the importance of PCGTs is just beginning
to emerge. Salient points are that (1) the DNA methyla-
tion signatures of a mixed cell population from human
blood during ageing and mouse intestinal cells mimicked
features common to both stem cells and cancer with re-
spect to PCGTs [4, 7]; (2) changes in DNA methylation
during the ageing of haematopoietic stem cells clustered
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Fig. 3 Measurement of mRNAs for PRC components, KDM2B and DNMTs under conditions of SIRT1 knockdown. Data are for HuVECs (a) and
Caco-2 cells (b). SIRT1 knockdown was achieved using two different siRNAs, as indicated. Measurements were by RT-qPCR. Data are mean ± SEM
for n = 6–15 relative to the reference genes GAPDH and TOP1 and normalised according to the measurements for the control siRNA. *P < 0.05;
**P < 0.01; ***P < 0.001 compared with control by one-way ANOVA then Dunnett’s post hoc test
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cumulation of DNA methylation changes in stem cells
(“epigenetic rejuvenation”) may reverse the ageing process
[10]. An effect of SIRT1 on DNA methylation at PCGTs is
a highly novel and important finding and is pertinent to
evaluating how the impact of SIRT1 on pleiotropic cellular
processes may affect healthspan.
We made this fundamentally important discovery con-
cerning actions of SIRT1 in two different cell lines using
approaches based on different principles both to enrichDNA for the methylated fraction and for downstream
detection of the enriched sequences. The discovery is
thus highly robust, and we make no attempt to confirm
effects by direct measurement of DNA methylation at
specific PCGTs. In contrast to techniques we could
apply for such measurements, neither approach we used
reports on DNA methylation at specific CpG sites. Both
approaches sample the total level of DNA methylation
across a fragment of DNA, whereas approaches to tar-
geted measurements (such as pyrosequencing, which we
AB
SIRT1 (120) kDa) 
-tubulin (55 kDa)
-tubulin (55 kDa)
EZH2 (85) kDa) 
siRNA
control
siRNA
SIRT1 #1
siRNA
SIRT1 #2
siRNA
control
siRNA
SIRT1 #1
siRNA
SIRT1 #2
Fig. 4 Measurement of EZH2 protein under conditions of SIRT1
knockdown. SIRT1 knockdown in Caco-2 cells was achieved using
two different siRNAs and protein was analysed by Western blotting
using anti-EZH2 antibody (a) or anti-SIRT1 antibody (to confirm
efficacy of knockdown) (b). Blots were probed with anti-α-tubulin
antibody to confirm equal protein loading and transfer. Approximately
10 μg of protein was loaded in each lane. Three biological replicates
are presented for each condition. Approximate molecular weights
are indicated
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of CpG sites. Thus, failure of targeted approaches to
validate findings based on genome-wide analysis may re-
flect sampling of unaffected CpG sites in the vicinity of
affected sites. Despite these caveats, we did observe that 4
of a panel of 10 genes (IRX3, PTPRG, STK10 and KLF3)
we found previously to show differential DNA methyla-
tion when the expression of SIRT1 was manipulated inAntibody
IP Western blot
SIRT1 SIRT1
SIRT1 EZH2
EZH2 EZH2
EZH2 SIRT1
120 kDa 
120 kDa 
80 kDa 
80 kDa 
Input IP-ve
IP
+ve
Fig. 5 Use of anti-SIRT1 and anti-EZH2 antibodies in co-
immunoprecipitation experiments. Anti-SIRT1 or anti-EZH2 antibody
was added to total cell lysate as indicated, but omitted from samples
labelled “IP -ve”. Immune complexes were captured on protein A/G
Sepharose then eluted and analysed, along with an equivalent
sample of the input protein, by Western blotting using anti-SIRT1 or
anti-EZH2 antibody, as indicated. Both antibodies when used for
immunoprecipitation and Western blotting confirmed self-enrichment
of the corresponding protein in the immunoprecipitated samples but
neither led to enrichment of the other protein. Approximate molecular
weights of proteins seen as specific bands are indicated. Data using
anti-SIRT1 antibody are for Caco-2 cells and are consistent with data
obtained using HuVECs. Data using anti-EZH2 antibody are for HuVECs
and are consistent with data obtained using Caco-2 cellsCaco-2 cells [16] were also detected as differentially meth-
ylated in the current analysis.
We reported previously the effect of SIRT1 knock-
down in Caco-2 cells on the transcriptome [16]. Com-
parison of the list of genes that underwent DNA
hypermethylation or hypomethylation in response to
SIRT1 knockdown with the list of genes for which we
detected a parallel change in expression revealed no sig-
nificant correlation. This finding is consistent with a
wider body of published data that reveals at best a weak
correlation between effects on DNA methylation and
gene expression. For example, correlation between age-
related changes in genome-wide DNA methylation in
haematopoietic stem cells, which clustered at genes reg-
ulated by PRC2, and changes in gene expression was low
[3], suggesting that effects are manifest at the level of
the transcriptome only when passed on to downstream
progeny or indirectly. Furthermore, studies in diverse
cell types have revealed that there is generally little cor-
relation between changes in genome-wide DNA methy-
lation and gene expression [35–37]. Reported weak
correlations between DNA methylation and gene expres-
sion were more pronounced for cell lineage-specific
genes where DNA methylation changes were in regula-
tory elements [3, 35]. The resolution of our current data
does not allow the identification of DNA methylation
changes that are specifically within regulatory elements.
Thus, attempting to validate our data on SIRT1-driven
effects on DNA methylation at PCGTs by measurement
of the response at the RNA level of these genes would
thus be of limited value.
A future priority should be to uncover in detail the
mechanism through which SIRT1 affects DNA methyla-
tion at PCGTs. Action mediated through the polycomb
group proteins is a highly plausible suggestion, given
that the PRCs affect the epigenetic status, including
DNA methylation, of PCGTs [31, 32]. We found no evi-
dence that the level of SIRT1 in the cell affects expres-
sion at the mRNA level of any of the components of
PRC1 or PRC2 or of KDM2B, which targets PRC1 to
CpG islands [33]. Our data do not exclude the possibility
that SIRT1 affects polycomb group protein expression
downstream of mRNA, and thus, measurement of the
effect of SIRT1 knockdown on polycomb group protein
level (e.g. by Western blotting) should be a future prior-
ity. Of the multiple components of the PRCs, EZH2 is
arguably the most likely candidate as the point at which
SIRT1 interacts to modify actions of the PRCs on DNA
methylation at their gene targets because EZH2 has been
shown to control DNA methylation through association
with DNMTs [32]. Also, direct intermolecular associ-
ation between recombinant, epitope-tagged SIRT1 and
EZH2 was observed in HeLa cells [34]. Moreover, tri-
methylation of H3K27 by EZH2 is an early event in the
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PRC binding to PCGTs and leads to recruitment of
PRC1 through chromodomain-containing components
[31]. However, we detected no intermolecular associ-
ation between SIRT1 and EZH2. The interaction ob-
served in HeLa cells may require the expression of the
two proteins at higher levels (as was the case in this pre-
vious work, by virtue of expression of recombinant pro-
teins from transgenes) or may be cell-line specific.
Moreover, the earlier work showed that SIRT1 is not a
component of PRC2 but associates with polycomb pro-
teins in PRC4, a specific PRC containing isoform 2 of
EED [34]. EED2 is expressed specifically in undifferenti-
ated pluripotent cells and also cancer cells. The same
work showed a direct association between SIRT1 and
SUZ12 using purified recombinant proteins. A priority
for future work is to determine if SIRT1 interacts dir-
ectly with other components of the PRCs and to deter-
mine by ChIP if SIRT1 binds directly to PCGTs or if its
effects on DNA methylation at these sites are indirect.
A factor to consider in interpreting the likely impli-
cations of age-associated changes in PCGT DNAFig. 6 A proposed model for age-associated drift in DNA methylation and
DNA methylation signature (blue), divides asymmetrically to generate a diff
(red) and a daughter stem cell. The fidelity with which the two daughter ce
of DNA methylation across the genome is compromised in ageing tissue suc
more skewed towards that of the differentiated cell and vice versa, as indicate
DNA methylation signatures. Additionally, the proportion of stem cells may in
drift in DNA methylation in a sample of stem cells, therefore, will be towa
however, where differentiated cells predominate, the drift in DNA methyla
methylation are to mimic the signature of the stem cell, rather than the d
on stem cells, where the correct (“younger”) DNA methylation signature is
signature at cell division, and thus restored tissue functionmethylation and the effects thereon of SIRT1 is the na-
ture of the cell population sampled and/or analysed,
specifically whether these be stem cells [3] or, princi-
pally, the differentiated progeny [4, 7]. Lack of stem-
ness in stem cells or gain of stem cell-like features in
the differentiated progeny could give rise to features of
tissue ageing. We propose a speculative model, based
on this premise, that can reconcile these observations
on DNA methylation changes in ageing cells, including
effects at PCGTs, with the observed effects thereon of
SIRT1 being a counteracting mechanism (Fig. 6). We
propose that the fidelity with which two daughter cells
that arise from asymmetric stem cell division acquire
the correct pattern of DNA methylation across the
genome is compromised in ageing tissue. Viz, the DNA
methylation pattern of the retained stem cell becomes
more skewed towards that of the differentiated cell and
vice versa. Epigenetic drift in a sample of ageing stem
cells, therefore, will be towards the epigenome of the
differentiated cell. In a mixed cell population, however,
where differentiated cells predominate (including in-
testine [4], as used to compile our list, and leukocytesrestorative effects of SIRT1. The stem cell, which has a characteristic
erentiated daughter cell with a different DNA methylation signature
lls that arise from this asymmetric division acquire the correct pattern
h that the DNA methylation pattern of the retained stem cell becomes
d by the increasing “blending” of the colours representing the different
crease in ageing tissue (by symmetric stem cell division). The age-related
rds the signature of the differentiated cell. In a mixed cell population,
tion is towards the signature of the stem cell. Effects of SIRT1 on DNA
ifferentiated cell; thus, beneficial effects on healthspan are via effects
restored, facilitating “corrected” partitioning of the DNA methylation
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of the stem cell. The more stem-like DNA methyla-
tion signature reflects faltering of the differentiation
process such that cells retain some of the signature
of their stem progenitors. Additionally, or alterna-
tively, as tissues age, the proportion of differentiated
versus stem cells may shift towards there being a
larger proportion of stem cells. Indeed, an expanded
proliferative zone has been observed in the intestinal
mucosa of older, compared with younger, rats and
humans [38, 39], and the number of clonogenic cells
per intestinal crypt on older mice, detected following
irradiation damage, exceeded eightfold the number
in younger mice [40]. We make the speculative sug-
gestion that effects of SIRT1 on DNA methylation
contribute to improved healthspan by restoring the
DNA methylation profile of stem cells, thus enhancing
tissue capacity to regenerate and restore function. We
propose that SIRT1 has these actions through association
with PRCs, which in turn modulates effects of these com-
plexes on DNA methylation. Thus, establishing rigorously
which polycomb proteins or combinations thereof co-
immunprecipitate with SIRT1 and mapping the sites on
the genome where these complexes bind are immediate
future priorities.
Conclusions
We show that effects of SIRT1 on DNA methylation
cluster at PCGTs. There is already robust evidence that
these loci are also hot spots for age-related changes in
DNA methylation. The discovery thus advances substan-
tially our understanding of how the pleiotropic effects of
SIRT1 may contribute to healthspan. Future research
should explore the mechanisms that account for these
effects of SIRT1 on DNA methylation at PCGTs and
how these actions then affect stem cell biology. Such
knowledge will point towards actions of SIRT1 whose
mimicry by lifestyle or pharmaceutical interventions may
contribute to a longer, healthier life.
Methods
Cell culture
Caco-2 cells were cultured under our standard labora-
tory conditions as described previously [41]. HuVECs
(passage 3) were seeded into 75-cm2 flasks at a density
of approximately 1 × 106 cells per flask and maintained
at 37 °C in a humidified atmosphere of 5 % CO2 in air in
EGM™ endothelial growth medium supplemented with
EGM™-2 BulletKit™. All tissue culture reagents were
supplied by Lonza. The medium was replaced twice
weekly. Experiments were carried out at passage 5–6 in
EGM™ endothelial growth medium supplemented with
2 % (v/v) fetal calf serum (Sigma) and 60 μg/ml genta-
mycin (Sigma).Overexpression and knockdown of SIRT1
Overexpression of SIRT1 in both Caco-2 cells and HuVECs
was achieved by transient transfection with the plasmid
pCMV6-ENTRY-SIRT1 (Origene), and knockdown of
SIRT1 was achieved using two different siRNAs and com-
pared with a control siRNA, as described previously for
Caco-2 cells [16]. Efficacy of overexpression and knock-
down was confirmed by RT-qPCR and Western blotting for
both cell lines as described previously for Caco-2 cells [16].
Preparation of DNA and enrichment for the methylated
fraction
DNA was extracted from HuVECs and Caco-2 cells
using the QIAamp® DNA Mini Kit (Qiagen). Enrichment
of HuVEC DNA for the methylated fraction was carried
out by NXT-DX, The Netherlands. DNA was fragmented
to an average length of 200 bp by sonication and ana-
lysed using the Agilent 2100 Bioanalyser (Agilent Tech-
nologies). Methylated DNA was captured using the
MethylCap kit (Diagenode), based on binding to methyl-
ated DNA of a recombinant H6-GST-MBD protein then
captured on magnetic beads coated with GSH. Caco-2
DNA was fragmented by sonication and purified from
agarose gels to produce DNA fragments ranging from
200–1000 bp in length. Purified fragmented DNA was
then spiked with unmethylated and methylated internal
controls generated from Lambda phage genomic DNA.
To generate these samples, two different fragments of
~500 bp in length were amplified by PCR from Lambda
phage dam− dcm− genomic DNA (Fermentas) using high
specificity HotStar Taq DNA polymerase (Qiagen) and
primer pairs AGCAACCAACAAGAAAACACT plus
TCATCCTCGGCAAACTCTTT and GTGAGGTGAAT
GTGGTGAAGT plus TCGCAGAGATAAAACACGCT.
An aliquot of each PCR product was then methylated
in vitro using SssI DNA methylase (New England Biolabs).
The methylation status of the unmethylated and methylated
controls was confirmed by digestion with the methylation-
sensitive restriction enzyme AciI (Fermentas). Spiked DNA
samples were denatured at 95 °C then incubated for 4 h at
4 °C with anti-5-methylcytidine (5mC) antibody (Eurogen-
tec) (12 μl per 4.5 μg DNA) in 10 mM Na-Phosphate pH
7.0, 140 mM NaCl, 0.05 % Triton X-100. DNA was then
captured using sheep anti-mouse IgG Dynabeads (Invitro-
gen), following the manufacturer’s instructions. Dynabeads
were then incubated with Proteinase K (Roche) at 50 °C for
2 h with shaking, and the beads were then removed using a
magnetic rack. DNA was then purified using the DNA
Clean and Concentrator 5 kit (Zymo Research). Whole
genome amplification of input or immunoprecipitated
DNA was then performed using the GenomePlex®
Complete Whole Genome Amplification kit (Sigma),
and retention of fragment size was confirmed by agarose
gel electrophoresis.
Wakeling et al. Human Genomics  (2015) 9:14 Page 9 of 11Analysis of differences in the DNA content of input versus
enriched pools
For each condition (SIRT1 overexpressed by transfection
with pCMV6-ENTRY-SIRT1, corresponding vector con-
trol, each of the siRNAs that target SIRT1 and control
siRNA), six biological replicates prepared from HuVECs
were pooled for analysis. Sequence reads were mapped to
hg19 using Bowtie2 [42] then filtered first to remove un-
mapped reads using Picard (http://picard.sourceforge.net/).
The GENCODE gene set [43] was then used to identify
genes, defined as within 2 kb of a TSS or within genes (be-
tween the TSS and stop codon). The package MEDIPS
(Bioconductor) was used to identify differentially methyl-
ated genes, which were then classified as hypomethylated
or hypermethylated when SIRT1 expression was increased
or reduced.
The methylation profile of DNA from Caco-2 cells
was measured using the DNA Methylation Service pro-
vided by NimbleGen. Input and methylation-enriched
samples were labelled with Cy3 and Cy5, respectively,
using the NimbleGen Dual-Colour DNA Labelling Kit
then co-hybridised to the Human 3x720K CpG Island
Plus RefSeq Promoter Array using the NimbleGen Hy-
bridisation System. The hybridised arrays were then
washed with the NimbleGen Wash Buffer Kit and dried
with the NimbleGen Microarray Drier, and signal peak
intensities for each probe were measured with the Nim-
bleGen MS 200 Microarray Scanner. Data were pro-
vided as signal intensity and P value for each probe.
These data were used to detect peaks through manual
inspection in Excel (Microsoft), accepting positive en-
richment being where at least two of three biological
replicates of each sample analysed (SIRT1 overexpressed
by transfection with pCMV6-ENTRY-SIRT1, corre-
sponding vector control, each of the siRNAs that target
SIRT1 and control siRNA) met a >2 P value minimum
cutoff.
RNA measurement by RT-qPCR
RNA was prepared using the PureLink RNA MiniKit (Life
Technologies) then reverse transcribed using SuperScript
III Reverse Transcriptase (Life Technoloiges), following
the manufacturer’s instructions. Quantitative real-time
PCR was performed in a Roche LightCycler 480 with 20
μl reactions set up in a 96-well format containing LightCy-
cler SYBR Green I Master (Roche), 0.5 μM of each primer
(see Additional file 2) and 1 μl of cDNA (reverse tran-
scription reaction diluted 1:4). After denaturing for 5 min
at 95 °C, 50 cycles were carried out using the following pa-
rameters: 95 °C, 10 s; 55 °C, 10 s; and 72 °C, 15 s. Levels of
specific RNAs relative to control, and corrected according
to levels of reference gene RNAs, were calculated using
the ΔΔCt method. PCR products were sequenced (Euro-
fins Genomics) to confirm identity.Immunoprecipitation
SIRT1 or EZH2 and proteins bound to them were co-
immunoprecipitated using the Classic IP kit (Pierce).
Cells were rinsed with 1× PBS and lysed with lysis/wash
buffer in volumes according to cell growth area, as recom-
mended by the manufacturer. Lysate samples (1000 μg
each) were pre-cleared with control agarose resin, followed
by overnight incubation at 4 °C with either 10 μg SIRT1
antibody (Abcam, ab7343) or 10 μg EZH2 antibody (R&D
Systems, AF4767). Negative controls were prepared in an
identical manner but omitting antibody. Immune com-
plexes were immobilised on protein A/G Sepharose col-
umns, which were washed three times with lysis/wash
buffer then once with conditioning buffer. Protein was
then eluted in elution buffer and concentration was
determined against BSA standards using Bradford re-
agent (Bio-Rad Laboratories).Western blotting
Immunoprecipitated proteins or total cell protein ex-
tract prepared as described previously [16] (10 μg) were
resolved by SDS-PAGE using 7 % gels then transferred
by semi-dry blotting onto PVDF membrane (Amer-
sham Hybond-P, GE Healthcare). Membranes were in-
cubated at room temperature for 1 h with constant
shaking first in Odyssey blocking buffer (LI-COR) then
with primary antibody (SIRT1 (Abcam, ab7343) or
EZH2 (R&D Systems, AF4767 )) diluted 1:250 in Odys-
sey blocking buffer supplemented with 0.1 % (v/v)
Tween-20. Membranes were washed five times for 15
min in 1× PBS plus 0.1 % (v/v) Tween-20 then incu-
bated for 1 h at room temperature with secondary
antibody (Odyssey LI-COR, IRDye® 680RD donkey anti-
rabbit IgG to detect anti-SIRT1 and IRDye® 800CW
donkey anti-goat IgG to detect EZH2) diluted 1:2000 in
Odyssey blocking buffer supplemented with 0.1 % (v/v)
Tween-20. The washing procedure was then repeated
before scanning membranes on the Odyssey LI-COR
infrared imaging system.Statistical analysis
Intersections between gene lists were tested for statis-
tical significance by chi-square analysis applying Yates’
correction. Data derived by RT-qPCR were analysed by
one-way ANOVA then Dunnett’s post hoc test.Availability of supporting data
The data sets supporting the results of this article are avail-
able in the Gene Expression Omnibus database (http://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE54072
and http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?ac
c=GSE53569).
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Additional file 1: Enrichment ratios of methylated DNA after MeDIP
compared to input DNA for Caco-2 cells.
Additional file 2: Primers used for qPCR.
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